NYR 3.39% 6.1¢ nyrada inc.

Ann: Nyrada Announces US Patent Grant for PCSK9 Inhibitor, page-17

  1. neg
    3,770 Posts.
    lightbulb Created with Sketch. 171
    They also ran an exploration program with a new Compound which they saw a good reduction in cholesterol
    in the first 14 days. They are looking to potentially have it as a backup or 2nd generation compound.

    Also the TBI program with the Walter Reid Army Institute, who is the D.O.D research group.
    Studies to be reported this year.

 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
0.002(3.39%)
Mkt cap ! $11.11M
Open High Low Value Volume
6.0¢ 6.1¢ 5.9¢ $30.56K 511.0K

Buyers (Bids)

No. Vol. Price($)
2 85425 5.7¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 159534 2
View Market Depth
Last trade - 15.01pm 22/08/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.